Literature DB >> 19234648

Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer.

Ravi Ramjeesingh1, May Lynn Quan, Sandra Gardner, Claire M B Holloway.   

Abstract

BACKGROUND: We sought to identify criteria for the intraoperative assessment of sentinel lymph node (SLN) involvement in women with early breast cancer. We also sought to determine whether the SLN nomogram developed by the Memorial Sloan-Kettering Cancer Center (MSKCC) to predict nonsentinel lymph node (NSLN) involvement when the SLN is positive would accurately predict NSLN involvement in our patient population.
METHODS: We performed 405 SLN biopsies in 397 women between January 1998 and June 2005. We determined factors associated with SLN metastases using univariate and multivariate logistic regression. Ninety women who had 1 positive SLN or more and underwent axillary lymph node dissection (ALND) had complete data for analysis. We applied the MSKCC nomogram retrospectively to this subset of women, and we calculated the probability of NSLN involvement and compared it with the observed rate.
RESULTS: Multifocality and the presence of lymphovascular invasion were predictive of SLN involvement. Ductal carcinoma in situ was negatively associated with SLN involvement. Intraoperative evaluation identified 57 (63%) of the 90 women with involved SLN, of which 26 (29%) had involved NSLN. Application of the MSKCC nomogram to our data set produced an area under the receiver operator characteristic curve of 0.71. The nomogram tended to overestimate the probability of NSLN involvement in our population.
CONCLUSION: Lymphovascular invasion and multifocality were associated with SLN involvement. Women with small low-grade tumours may not require routine intraoperative evaluation of SLNs. The MSKCC nomogram appears to be most useful as a decision aid in selecting those women with an involved SLN in whom ALND may be omitted.

Entities:  

Mesh:

Year:  2009        PMID: 19234648      PMCID: PMC2637641     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  46 in total

1.  Role of axillary ultrasound examination in the selection of breast cancer patients for sentinel node biopsy.

Authors:  Jacopo Nori; Ermanno Vanzi; Massimo Bazzocchi; Filippo Nori Bufalini; Vito Distante; Francesco Branconi; Tommaso Susini
Journal:  Am J Surg       Date:  2007-01       Impact factor: 2.565

2.  Sentinel lymph node biopsy in breast cancer: Canadian practice patterns.

Authors:  Geoffrey A Porter; Heather McMulkin; Peter J Lovrics
Journal:  Ann Surg Oncol       Date:  2003-04       Impact factor: 5.344

3.  Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer.

Authors:  S F Abdessalam; E E Zervos; M Prasad; W B Farrar; L D Yee; M J Walker; W B Carson; W E Burak
Journal:  Am J Surg       Date:  2001-10       Impact factor: 2.565

4.  Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy.

Authors:  Maureen A Chung; Margaret M Steinhoff; Blake Cady
Journal:  Am J Surg       Date:  2002-10       Impact factor: 2.565

5.  Predictors of nonsentinel lymph node metastasis in breast cancer patients.

Authors:  Ulka Sachdev; Kara Murphy; Alain Derzie; Shabnam Jaffer; Ira J Bleiweiss; Steven Brower
Journal:  Am J Surg       Date:  2002-03       Impact factor: 2.565

6.  Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy.

Authors:  M P Schijven; A J J M Vingerhoets; H J T Rutten; G A P Nieuwenhuijzen; R M H Roumen; M E van Bussel; A C Voogd
Journal:  Eur J Surg Oncol       Date:  2003-05       Impact factor: 4.424

7.  Removal of two sentinel nodes accurately stages the axilla in breast cancer.

Authors:  R J Kennedy; J Kollias; P G Gill; M Bochner; B J Coventry; G Farshid
Journal:  Br J Surg       Date:  2003-11       Impact factor: 6.939

8.  Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run.

Authors:  Coen W Hurkmans; Jacques H Borger; Emiel J Th Rutgers; Geertjan van Tienhoven
Journal:  Radiother Oncol       Date:  2003-09       Impact factor: 6.280

9.  A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy.

Authors:  Kimberly J Van Zee; Donna-Marie E Manasseh; Jose L B Bevilacqua; Susan K Boolbol; Jane V Fey; Lee K Tan; Patrick I Borgen; Hiram S Cody; Michael W Kattan
Journal:  Ann Surg Oncol       Date:  2003-12       Impact factor: 5.344

10.  Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma.

Authors:  Aleodor A Andea; David Bouwman; Tracie Wallis; Daniel W Visscher
Journal:  Cancer       Date:  2004-01-01       Impact factor: 6.860

View more
  7 in total

1.  Associated Features with Non-Sentinel Lymph Node Involvement in Early Stage Breast Cancer Patients who Have Positive Macrometastatic Sentinel Lymph Node.

Authors:  Hakan Ataş; Buket Altun Özdemir; Ebru Menekşe; Sabri Özden; Yunus Nadi Yüksek; Gül Dağlar
Journal:  Eur J Breast Health       Date:  2020-04-17

Review 2.  Prognostic factors in elderly patients with breast cancer.

Authors:  Alessandro Cappellani; Maria Di Vita; Antonio Zanghì; Andrea Cavallaro; Gaetano Piccolo; Marcello Majorana; Giuseppina Barbera; Massimiliano Berretta
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

3.  Multicenter validation of two nomograms to predict non-sentinel node involvement in breast cancer.

Authors:  Antonio Piñero; Manuel Canteras; Arancha Moreno; Francisco Vicente; Julia Giménez; Ana Tocino; Edelmiro Iglesias; Sergi Vidal-Sicart; Luzdivina Santamaría; Miguel Lorenzo; Manuel García; Diego Ramirez
Journal:  Clin Transl Oncol       Date:  2012-07-25       Impact factor: 3.405

4.  A logistic regression model for predicting axillary lymph node metastases in early breast carcinoma patients.

Authors:  Fei Xie; Houpu Yang; Shu Wang; Bo Zhou; Fuzhong Tong; Deqi Yang; Jiaqing Zhang
Journal:  Sensors (Basel)       Date:  2012-07-23       Impact factor: 3.576

5.  Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer.

Authors:  Thuraya S Alsumai; Norah Alhazzaa; Abdullah Alshamrani; Sarah Assiri; Amal Alhefdhi
Journal:  Breast Cancer (Dove Med Press)       Date:  2022-10-11

6.  Evaluation of the benefit of routine intraoperative frozen section analysis of sentinel lymph nodes in breast cancer.

Authors:  C M T P Francissen; R F D van la Parra; A H Mulder; A M Bosch; W K de Roos
Journal:  ISRN Oncol       Date:  2013-09-16

7.  Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node.

Authors:  Yidong Zhou; Xin Huang; Feng Mao; Yan Lin; Songjie Shen; Jinghong Guan; Xiaohui Zhang; Qiang Sun
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.